Top Markets
Coin of the day
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Rang in aandelen #26682
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Aandeelprijs
$3.49
Laatst gesynchroniseerd: 2023-12-19
Marktkapitalisatie
$38.68M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Neoleukin Therapeutics, Inc. (NLTX)

Categorie

Koersgeschiedenis voor Neoleukin Therapeutics, Inc. (NLTX)
Hoogste slotkoers: $3.45 op 2023-12-01

Laagste slotkoers: $64.26 op 2014-03-01
Koersgeschiedenis van Neoleukin Therapeutics, Inc. van 2014 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2023 54.08%
2022 -91.29%
2021 -59.35%
2020 43.82%
2019 289.17%
2018 -79.56%
2017 -28.51%
2016 28.68%
2015 63.39%
2014 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$171.67 -
DE
$163.33 25.54%
DE
$38.00 22.72%
JP
$220.12 32.96%
CH
$21.01 11.96%
IN